Skip to content
healthcare.dev

NYPOZI txid

NDC 72374-101, filgrastim-txid, injection, from Tanvex BioPharma USA, Inc..

Product NDC
72374-101
Status
Listed
Labeler
Tanvex BioPharma USA, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761126
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72374-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FILGRASTIM300 ug/300ug

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
72374-101-01723740101011 SYRINGE, GLASS in 1 CARTON (72374-101-01) / 300 ug in 1 SYRINGE, GLASS
72374-101-107237401011010 SYRINGE, GLASS in 1 CARTON (72374-101-10) / 300 ug in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89092bb8-6a20-e23e-e053-2a95a90aa750
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72374-101

Use it

Look up 72374-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72374-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72374-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.